Publications by authors named "Kimberly Langer"

Article Synopsis
  • - Post-transplant cyclophosphamide (PT-Cy) is becoming the standard treatment to prevent graft-versus-host disease (GVHD) in patients who undergo allogeneic hematopoietic stem cell transplant (alloHCT), but it can cause endothelial damage.
  • - The study investigates whether the endothelial activation and stress index (EASIX) score can predict non-relapse mortality (NRM) in patients receiving PT-Cy, alongside the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) and other survival factors.
  • - Findings from analyzing 199 patients reveal that a high EASIX score significantly correlates with increased NRM (34.5% vs. 12
View Article and Find Full Text PDF

Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative option for many hematologic conditions and is associated with considerable morbidity and mortality. Therefore, prognostic tools are essential to navigate the complex patient, disease, donor, and transplant characteristics that differentially influence outcomes. We developed a novel, comprehensive composite prognostic tool.

View Article and Find Full Text PDF

Background: Improving care of critically ill patients requires using an interprofessional care model and care standardisation.

Objectives: Determine whether collaborative patient care rounds in the intensive care unit increases practice consistency with respect to common considerations such as delirium prevention, device use, and indicated prophylaxis, among others. Secondary objective to assess whether collaborative interprofessional format improved nursing perceptions of collaboration.

View Article and Find Full Text PDF

We carried out the first matched retrospective cohort study aimed at studying the safety and efficacy of extracorporeal photopheresis (ECP) for bronchiolitis obliterans syndrome (BOS) after allogeneic hematopoietic cell transplantation (HCT). Medical records of 1325 consecutive adult patients who underwent HCT between 2005 and 2015 were reviewed. Seventy-four patients (median age, 51 years) with a diagnosis of BOS were included in the study.

View Article and Find Full Text PDF